Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if giving 5-aza-2 deoxycytidine
(decitabine) in combination with Mylotarg (gemtuzumab ozogamicin) can help to control AML or
high-risk MDS. The safety of this drug combination will also be studied.